New incident report
Incident Report Number: 2023-1697
Registrant Reference Number: 2023-CA-000042
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: CANADA
Prov / State: BRITISH COLUMBIA
Unknown
PMRA Registration No. 31724 PMRA Submission No. EPA Registration No.
Product Name: Hartz UltraGuard Rid Flea Oatmeal Dog Shampoo 18 oz Shampoo
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Unknown
Animal's Owner
Dog / Chien
Yorkshire Terrier
1
Male
9
2.7
kg
Skin
>1 mo <= 6 mos / > 1 mois < = 6 mois
>2 hrs <=8 hrs / > 2 h < = 8 h
System
>3 days <=1 wk / >3 jours <=1 sem
Yes
No
Fully Recovered / Complètement rétabli
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On an unknown date in approximately Jan-2023, a 9 year old, approximately 2.7 kilogram, neutered, male, Yorkshire Terrier dog, in unknown condition, with no known concomitant medical conditions, was administered 1 application of Hartz UltraGuard Rid Flea Oatmeal Dog Shampoo 18 oz (Phenothrin (Sumithrin)) via the topical route by the animal owner. Approximately six hours post product administration, the dog developed red, irritated skin that started to scab and fall off. The dog was evaluated by a veterinarian on an unspecified date and prescribed a medicated ointment (unspecified active ingredients) to be applied topically to the wounds and meloxicam to be given orally by the animal owner, as directed by the veterinarian. The clinical signs resolved approximately three days later. On approximately 09-Feb-2023, the dog was again administered 1 application of Hartz UltraGuard Rid Flea Oatmeal Dog Shampoo 18 oz (Phenothrin (Sumithrin)) via the topical route by the animal owner. The same clinical signs developed approximately six hours post administration and the dog was administered the same two medications by the animal owner, as directed by the veterinarian. On approximately 13-Feb-2023, the clinical signs resolved and the dog recovered. The animal owner had a difficult time providing specific dates in this case. No further information is expected.
Moderate
Assessment: The active ingredient is present in very low concentration in this product and has a wide margin of safety in dogs. While the signs reported in this case are not anticipated following labeled use of the product, an animal may have an individual sensitivity to any one of the product ingredients leading to a reaction. Such reactions are difficult to predict. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.